These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20924879)

  • 1. Advanced urine toxicology testing.
    Tenore PL
    J Addict Dis; 2010 Oct; 29(4):436-48. PubMed ID: 20924879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety.
    Mikel C; Pesce AJ; Rosenthal M; West C
    Clin Chim Acta; 2012 Aug; 413(15-16):1199-202. PubMed ID: 22484396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive buprenorphine EIA urine toxicology results due to high dose morphine: a case report.
    Tenore PL
    J Addict Dis; 2012; 31(4):329-31. PubMed ID: 23244551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can a methadone and an opiate-positive immunoassay result be reconciled in a patient prescribed only OxyContin and Wellbutrin?
    Abadie JM
    Ann Clin Lab Sci; 2013; 43(2):190-4. PubMed ID: 23694796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
    Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
    Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of unconjugated morphine, codeine and 6-acetylmorphine in urine specimens from suspected drugged drivers.
    Ceder G; Jones AW
    J Forensic Sci; 2002 Mar; 47(2):366-8. PubMed ID: 11908609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
    Gingras M; Laberge MH; Lefebvre M
    J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized elderly medical patients.
    Glintborg B; Olsen L; Poulsen H; Linnet K; Dalhoff K
    Clin Toxicol (Phila); 2008 Mar; 46(3):239-42. PubMed ID: 18344106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poppy seed foods and opiate drug testing--where are we today?
    Lachenmeier DW; Sproll C; Musshoff F
    Ther Drug Monit; 2010 Feb; 32(1):11-8. PubMed ID: 19901868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
    Dale RC; Ford LT; Street C
    Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of opiate use.
    Stefanidou M; Athanaselis S; Spiliopoulou C; Dona A; Maravelias C
    Int J Clin Pract; 2010 Nov; 64(12):1712-8. PubMed ID: 20946276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of techniques to detect illicit heroin use in patients prescribed pharmaceutical heroin for the management of opioid dependence.
    Paterson S; Lintzeris N; Mitchell TB; Cordero R; Nestor L; Strang J
    Addiction; 2005 Dec; 100(12):1832-9. PubMed ID: 16367984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: the Pacific perspective.
    Selavka CM
    J Forensic Sci; 1991 May; 36(3):685-96. PubMed ID: 1856638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine toxicology testing in chronic pain management.
    Cone EJ; Caplan YH
    Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.